CVS
NYSEHealthcareLoading…
CVS Health Corporation Common Stock
Sector: Healthcare•United States•Market Cap: $91.8B
Related News
Latest stories connected to CVS
10/17More news →
- RS 74CVS to Grow Store Footprint This Year With 60 New LocationsWSJ•1d ago•Original source
- RS 74CVS Pharmacy® celebrates opening of first pharmacy-only location in ChicagoPRNewsWire•1d ago•Original source
- RS 74CVS Health's Discounted Buying Opportunity Is Here - Robust Fundamentals And Secure DividendsSeeking Alpha•6d ago•Original source
- RS 74Wall Street Bulls Look Optimistic About CVS Health (CVS): Should You Buy?Zacks Investment Research•Mar 24, 2026•Original source
- RS 74Bernstein Litowitz Berger & Grossmann Announces Filing of Racketeering Class Action Against CaremarkPCS and CVS Health CorporationBusiness Wire•Mar 19, 2026•Original source
- RS 74CVS Health Corporation (CVS) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research•Mar 19, 2026•Original source
- RS 74CVS Health declares quarterly dividendPRNewsWire•Mar 18, 2026•Original source
- RS 74Why Is CVS Health (CVS) Down 1.7% Since Last Earnings Report?Zacks Investment Research•Mar 12, 2026•Original source
- RS 74CVS Health Foundation Invests $2.24 Million to Expand Community‑Based Care Through Health Impact OhioPRNewsWire•Mar 10, 2026•Original source
Financials
| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|
| Revenue | 402.07B | 372.81B | 357.78B | 322.47B | 292.11B | 268.71B | 256.78B | 194.58B | 184.79B | 177.55B |
| Cost of Revenue | 346.70B | 321.41B | 303.35B | 267.96B | 239.99B | 219.66B | 211.25B | 163.04B | 156.26B | 148.71B |
| Gross Profit | 55.36B | 51.40B | 54.43B | 54.50B | 52.12B | 49.05B | 45.53B | 31.54B | 28.53B | 28.83B |
| Research and Development Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General and Administrative Expenses | 0 | 40.24B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling and Marketing Expenses | 0 | 989.00M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General and Administrative Expenses | 0 | 41.23B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses | 44.98B | 1.66B | 40.69B | 46.55B | 38.81B | 35.13B | 33.54B | 27.52B | 18.99B | 18.45B |
| Operating Expenses | 44.98B | 42.88B | 40.69B | 46.55B | 38.81B | 35.13B | 33.54B | 27.52B | 18.99B | 18.45B |
| Cost and Expenses | 391.68B | 364.29B | 344.03B | 314.51B | 278.80B | 254.79B | 244.79B | 190.56B | 175.25B | 167.16B |
| Net Interest Income | -3.12B | -2.96B | -2.66B | -2.29B | -2.50B | -2.91B | -3.04B | -2.62B | -1.06B | -1.06B |
| Interest Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 20.00M |
| Interest Expense | 3.12B | 2.96B | 2.66B | 2.29B | 2.50B | 2.91B | 3.04B | 2.62B | 1.06B | 1.08B |
| Depreciation and Amortization | 0 | 4.60B | 4.37B | 4.22B | 4.49B | 4.44B | 4.37B | 2.72B | 2.48B | 2.48B |
| EBITDA | 9.86B | 13.68B | 18.20B | 12.35B | 17.53B | 17.12B | 16.40B | 6.74B | 11.81B | 12.19B |
| EBIT | 5.25B | 9.11B | 13.83B | 8.12B | 13.04B | 12.68B | 12.03B | 4.03B | 9.33B | 9.71B |
| Non Operating Income Excluding Interest | 5.13B | -590.00M | -88.00M | -169.00M | 270.00M | 1.23B | -45.00M | -4.00M | 208.00M | 671.00M |
| Operating Income | 10.38B | 8.52B | 13.74B | 7.95B | 13.31B | 13.91B | 11.99B | 4.02B | 9.54B | 10.39B |
| Total Other Income Expenses Net | -8.25B | -2.37B | -2.57B | -2.12B | -2.77B | -4.14B | -2.99B | -2.62B | -1.27B | -1.75B |
| Income Before Tax | 2.14B | 6.15B | 11.17B | 5.84B | 10.54B | 9.77B | 9.00B | 1.41B | 8.27B | 8.64B |
| Income Tax Expense | 408.00M | 1.56B | 2.81B | 1.51B | 2.55B | 2.57B | 2.37B | 2.00B | 1.64B | 3.32B |
| Net Income From Continuing Operations | 1.73B | 4.59B | 8.37B | 4.33B | 7.99B | 7.20B | 6.63B | -596.00M | 6.63B | 5.32B |
| Net Income From Discontinued Operations | 0 | 0 | 0 | 0 | 0 | -9.00M | 0 | 0 | 0 | 0 |
| Other Adjustments To Net Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income | 1.77B | 4.59B | 8.37B | 4.33B | 7.99B | 7.19B | 6.63B | -596.00M | 6.62B | 5.32B |
| Net Income Deductions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Borrom Line Net Income | — | — | — | — | — | — | — | — | — | — |
| EPS | 1.4 | 3.66 | 6.49 | 3.29 | 6 | 5.48 | 5.1 | -0.57 | 6.47 | 4.93 |
| EPS Diluted | 1.39 | 3.66 | 6.47 | 3.26 | 5.95 | 5.46 | 5.08 | -0.57 | 6.44 | 4.9 |
| Weighted Average SHS Out | 1.27B | 1.26B | 1.28B | 1.31B | 1.32B | 1.31B | 1.30B | 1.04B | 1.02B | 1.07B |
| Weighted Average SHS Out Dil | 1.27B | 1.26B | 1.29B | 1.32B | 1.33B | 1.31B | 1.30B | 1.04B | 1.02B | 1.08B |
| Fiscal Year (FMP) | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K | 2.02K |
| Gross Profit Margin | 0.14 | 0.14 | 0.15 | 0.17 | 0.18 | 0.18 | 0.18 | 0.16 | 0.15 | 0.16 |
| R&D to Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A to Revenue | 0 | 0.11 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Interest Burden | 0.41 | 0.68 | 0.81 | 0.72 | 0.81 | 0.77 | 0.75 | 0.35 | 0.89 | 0.89 |
| EBIT Margin | 0.01 | 0.02 | 0.04 | 0.03 | 0.04 | 0.05 | 0.05 | 0.02 | 0.05 | 0.05 |
| EBITDA Margin | 0.02 | 0.04 | 0.05 | 0.04 | 0.06 | 0.06 | 0.06 | 0.03 | 0.06 | 0.07 |
| EBT per EBIT | 0.21 | 0.72 | 0.81 | 0.73 | 0.79 | 0.7 | 0.75 | 0.35 | 0.87 | 0.83 |
| Effective Tax Rate | 0.19 | 0.25 | 0.25 | 0.26 | 0.24 | 0.26 | 0.26 | 1.42 | 0.2 | 0.38 |
| Tax Burden | 0.83 | 0.75 | 0.75 | 0.74 | 0.76 | 0.73 | 0.74 | -0.42 | 0.8 | 0.62 |
| Cont. Operations Profit Margin | 0 | 0.01 | 0.02 | 0.01 | 0.03 | 0.03 | 0.03 | -0 | 0.04 | 0.03 |
| Bottom Line Profit Margin | 0 | 0.01 | 0.02 | 0.01 | 0.03 | 0.03 | 0.03 | -0 | 0.04 | 0.03 |
| Operating Cycle | 56.37 | 56.27 | 57.63 | 56.88 | 57.54 | 60.27 | 58.15 | 69.9 | 61.77 | 61.23 |
| Fwd PEG Ratio | -0.92 | -0.28 | 0.13 | -0.63 | 1.79 | 1.67 | -0.01 | 1.06 | 0.36 | 2.75 |
| Earnings Yield | 0.02 | 0.08 | 0.08 | 0.04 | 0.06 | 0.08 | 0.07 | -0.01 | 0.09 | 0.06 |
| Income Quality | 6.02 | 1.99 | 1.6 | 3.74 | 2.29 | 2.21 | 1.94 | -14.87 | 1.21 | 1.91 |